Incidence of death or BPD does not differ with expectant management versus active treatment for preterm infants with protocol-defined PDA.

Risk-based screening is noninferior to annual screening for detecting stage ≥IIB cancers, does not reduce biopsy rates despite fewer mammograms.

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

Severe valvular heart disease (VHD) is prevalent among patients with cancer and is associated with reduced survival.

Ketamine for anesthesia does not lower in-hospital death by day 28 compared with etomidate among critically ill adults undergoing tracheal intubation.

Nearly 1 in 4 Americans believe the US health care system is in crisis, and high costs are the top reason why.

For patients with node-negative breast cancer, omission of sentinel lymph node biopsy results in noninferior 5-year recurrence rates and survival.

The FDA is expected to decide on treatments for breast cancer, EBV+ post-transplant lymphoproliferative disease, focal segmental glomerulosclerosis, presbyopia, and severe allergic reactions.

The CDC has rescinded its long-standing advice on universal hepatitis B vaccination of newborns within 24 hours of birth.

Older age, certain comorbidities, and immunosuppression increase risk for severe West Nile disease and mortality.

Flu season is getting an early start in New York City, with emergency rooms seeing a sharp jump in flu patients.

An AHA scientific statement explores how AI, mobile imaging, and telehealth support acute stroke triage and treatment decisions within virtual networks.